Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ TD SYNNEX declares $0.48 dividend (SeekingAlpha) +++ TD SYNNEX Aktie -5,52%

HB FULLER Aktie

 >HB FULLER Aktienkurs 
52 EUR    -8.8%    (TradegateBSX)
Ask: 52.5 EUR / 290 Stück
Bid: 51.5 EUR / 300 Stück
Tagesumsatz: 35 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
HB FULLER Aktie über LYNX handeln
>HB FULLER Performance
1 Woche: +1,3%
1 Monat: +14,3%
3 Monate: +26,1%
6 Monate: +11,8%
1 Jahr: +16,3%
laufendes Jahr: +10,7%
>HB FULLER Aktie
Name:  H.B. FULLER
Land:  USA
Sektor:  Chemie
ISIN/ Wkn:  US3596941068 / 861402
Symbol/ Ticker:  HB1 (Frankfurt) / FUL (NYSE)
Kürzel:  FRA:HB1, ETR:HB1, HB1:GR, NYSE:FUL
Index:  -
Webseite:  http://www.hbfuller.com/
Profil:  H.B. Fuller Co. is a global supplier of adhesives, sealants, and other specialty chemical products, primarily serving the industrial and packaging sectors. Founded in 1887 and headquartered in St. Paul, Minnesota, the company has established itself a..
>Volltext..
Marktkapitalisierung:  3078.74 Mio. EUR
Unternehmenswert:  4751.71 Mio. EUR
Umsatz:  3036.29 Mio. EUR
EBITDA:  494.21 Mio. EUR
Nettogewinn:  140.37 Mio. EUR
Gewinn je Aktie:  2.58 EUR
Schulden:  1824.06 Mio. EUR
Liquide Mittel:  94.78 Mio. EUR
Operativer Cashflow:  274.5 Mio. EUR
Bargeldquote:  0.16
Umsatzwachstum:  -14.44%
Gewinnwachstum:  24.7%
Dividende je Aktie:  0.81 EUR
Dividendenrendite:  1.48%
Dividendenschätzung:  1.52%
Div. Historie:  30.04.26 - 0.2079315€
05.02.26 - 0.19916251€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  HB FULLER, H B FULLER, H.B. FULLER
Letzte Datenerhebung:  25.06.26
>HB FULLER Kennzahlen
Aktien/ Unternehmen:
Aktien: 54.49 Mio. St.
Frei handelbar: 99.49%
Rückkaufquote: 0.09%
Mitarbeiter: 7100
Umsatz/Mitarb.: 0.43 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 9.13%
Bewertung:
KGV: 23.05
KGV lG: 13.33
KUV: 0.94
KBV: 1.76
PEG-Ratio: 0.44
EV/EBITDA: 9.61
Rentabilität:
Bruttomarge: 31.88%
Gewinnmarge: 4.62%
Operative Marge: 11.01%
Managementeffizenz:
Gesamtkaprendite: 3.14%
Eigenkaprendite: 8.32%
>HB FULLER Peer Group
Chemie, Spezialchemie
 
25.06.26 - 12:48
Warum die Aktie von H B Fuller heute nachgibt (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
25.06.26 - 11:18
Advanced Medical Solutions agrees to £715 million takeover by Fuller (Alliance)
 
Advanced Medical Solutions Group PLC on Thursday said it has agreed to an all-cash takeover offer from US suitor HB Fuller Co...
25.06.26 - 10:06
Advanced Medical Solutions soars 16% as H.B. Fuller seals £715 million takeover (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
25.06.26 - 09:49
H.B. Fuller übernimmt britische Advanced Medical Solutions für 942 Millionen US-Dollar (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
25.06.26 - 08:33
H.B. Fuller to acquire Advanced Medical Solutions for £715M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
25.06.26 - 08:12
H.B. Fuller Announces Offer to Acquire Advanced Medical Solutions (Business Wire)
 
Extends capabilities in attractive, high-growth medical segments Accelerates portfolio mix shift and path to >20% EBITDA margin target Expected to deliver ~$55 million in run-rate synergiesST. PAUL, Minn.--(BUSINESS WIRE)--H.B. Fuller Company (“H.B. Fuller” or “the Company”) (NYSE: FUL), the world's largest pureplay adhesives company, today announced it has made a recommended cash offer to acquire Advanced Medical Solutions Group plc (“AMS”) (LSE:AMS). “This transaction is a rare opportunity to advance the evolution of our portfolio.” said Celeste Mastin, President and CEO of H.B. Fuller. “We have long been clear that medical is a core strategic growth market for H.B. Fuller given its durable demand trends, high regulatory-based entry barriers, and margin profile. Accordingly, we have thoroughly analyzed this structurally scarce market to identify the most attractive assets and growth opportunities. “Advanced Medical Solutions has built an exceptional business as a differentiated form...
25.06.26 - 08:01
H.B. Fuller Nears £628 Million Deal for UK Medtech AMS (Bloomberg)
 
H.B. Fuller Co. is close to an agreement to acquire Advanced Medical Solutions Group Plc in a deal valuing the equity of the British maker of tissue-healing medical products at £628 million ($827 million)....
25.06.26 - 01:00
H. B. Fuller (FUL) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
 
The headline numbers for H. B. Fuller (FUL) give insight into how the company performed in the quarter ended May 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals....
25.06.26 - 01:00
H. B. Fuller (FUL) Tops Q2 Earnings and Revenue Estimates (Zacks)
 
H. B. Fuller (FUL) delivered earnings and revenue surprises of +3.05% and +2.52%, respectively, for the quarter ended May 2026. Do the numbers hold clues to what lies ahead for the stock?...
24.06.26 - 22:09
H.B. Fuller Non-GAAP EPS of $1.41 beats by $0.03, revenue of $950M beats by $25.21M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
24.06.26 - 22:06
H.B. Fuller Reports Second Quarter 2026 Results (Business Wire)
 
Reported EPS (diluted) of $1.23; Adjusted EPS (diluted) of $1.41, up 19% year-on-year Net income of $68 million; Adjusted EBITDA of $181 million, up 9% year-on-year Record second quarter operating cash flow; Repurchased 750 thousand shares in the quarter Increases midpoint of full-year adjusted EBITDA and adjusted EPS guidanceST. PAUL, Minn.--(BUSINESS WIRE)--H.B. Fuller Company (NYSE: FUL) today reported financial results for its second quarter that ended May 30, 2026. Second Quarter 2026 Noteworthy Items: Net revenue was $950 million, up 5.8% year-on-year; organic revenue was up 2.6% year-on-year; Gross margin was 33.6%; adjusted gross margin of 34.2% increased 200 basis points year-on-year driven mainly by pricing execution and restructuring savings; Net income was $68 million; adjusted EBITDA was $181 million, up 9% versus last year; adjusted EBITDA margin was 19.1%, up 70 basis points year-on-year; Reported EPS (diluted) was $1.23; adjusted EPS (diluted) was $1.41, up 19% year-on-year, driven by high...
23.06.26 - 23:39
H.B. Fuller Q2 2026 Earnings Preview (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
19.06.26 - 19:45
Will H. B. Fuller (FUL) Beat Estimates Again in Its Next Earnings Report? (Zacks)
 
H. B. Fuller (FUL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report....
18.06.26 - 18:12
IN BRIEF: Advanced Medical Solutions extends HB Fuller offer deadline (Alliance)
 
Advanced Medical Solutions Group PLC - Cheshire, England-based surgical dressings company - Announces the extension of the...
18.06.26 - 16:45
Seeking Clues to H. B. Fuller (FUL) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics (Zacks)
 
Besides Wall Street's top-and-bottom-line estimates for H. B. Fuller (FUL), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended May 2026....
10.06.26 - 22:06
H.B. Fuller to Report Second Quarter 2026 Results on June 24, 2026 (Business Wire)
 
ST. PAUL, Minn.--(BUSINESS WIRE)--H.B. Fuller Company (NYSE: FUL) announced plans to report its financial results for the three-month fiscal period ended May 30, 2026, in a press release issued after the market close on June 24, 2026. The Company will hold an investor conference call on June 25, 2026, at 9:30 a.m. CT (10:30 a.m. ET) to discuss its financial results. Interested parties may listen to the conference call on a live webcast. The webcast, along with a supplemental presentation, may be accessed from the company's website at https://investors.hbfuller.com. Participants must register prior to accessing the webcast using this link and should do so at least 10 minutes prior to the start of the call to install and test any necessary software and audio connections. Participants can pre-register for the webcast at any time using the link above. The webcast will be archived on the company's website. A telephone replay of the conference call will be available from 12:30 p.m. CT on June 25, 2026 to 10:5...
02.06.26 - 17:30
FUL Expands Sustainable Packaging Portfolio With VerdaFresh (Zacks)
 
H.B. Fuller invests in VerdaFresh to boost recyclable packaging, helping cut waste and lower material use and carbon impact....
27.05.26 - 20:48
H.B. Fuller Has Great Assets For Potential Buyers: Chadwick (Bloomberg)
 
Jim Chadwick, president of Ancora Alternatives, joins Dani Burger on "Bloomberg Deals." Activist investor Ancora is pushing US adhesives maker H.B. Fuller to abandon a proposed takeover of UK-based Advanced Medical Solutions Group. (Source: Bloomberg)...
26.05.26 - 17:36
Activist Ancora wants H.B. Fuller to abandon bid for UK′s AMS (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
26.05.26 - 14:24
Activist Ancora Pushes H.B. Fuller to Drop Bid for UK′s AMS (Bloomberg)
 
Activist investor Ancora Holdings Group is pushing US adhesives maker H.B. Fuller Co. to abandon a proposed takeover of UK-based Advanced Medical Solutions Group Plc....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Die Zeit bringt auch dem Ungeduldigsten das Warten bei. - Elfriede Hablé
>Aktien | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!